Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Post-marketing multicenter study of Tecfidera in Chinese patients with relapsing multiple sclerosis
CTR20230654Phase 4Completed
- Sponsor
- Biogen
- Start
- Jun 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of dimethyl fumarate in multiple sclerosis (MS), sponsored by Biogen. Started Jun 2023; status: completed.
02
Drugs
dimethyl fumarate
03
Conditions
multiple sclerosis (MS)
Beyond the preview
Go deeper on CTR20230654.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20230654.